• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验中使用正态近似法的临时治疗选择。

Interim treatment selection using the normal approximation approach in clinical trials.

作者信息

Shun Zhenming, Lan K K Gordon, Soo Yuhwen

机构信息

Sanofi-Aventis, Bridgewater, NJ 08807, USA.

出版信息

Stat Med. 2008 Feb 20;27(4):597-618. doi: 10.1002/sim.2990.

DOI:10.1002/sim.2990
PMID:17619239
Abstract

We consider a study starting with two treatment groups and a control group with a planned interim analysis. The inferior treatment group will be dropped after the interim analysis, and only the winning treatment and the control will continue to the end of the study. This 'Two-Stage Winner Design' is based on the concepts of multiple comparison, adaptive design, and winner selection. In a study with such a design, there is less multiplicity, but more adaptability if the interim selection is performed at an early stage. If the interim selection is performed close to the end of the study, the situation becomes the conventional multiple comparison where Dunnett's method may be applied. The unconditional distribution of the final test statistic from the 'winner' treatment is no longer normal, the exact distribution of which is provided in this paper, but numerical integration is needed for its calculation. To avoid complex computations, we propose a normal approximation approach to calculate the type I error, the power, the point estimate, and the confidence intervals. Due to the well understood and attractive properties of the normal distribution, the 'Winner Design' can be easily planned and adequately executed, which is demonstrated by an example. We also provide detailed discussion on how the proposed design should be practically implemented by optimizing the timing of the interim look and the probability of winner selection.

摘要

我们考虑一项研究,该研究从两个治疗组和一个对照组开始,并计划进行中期分析。在中期分析后,较差的治疗组将被淘汰,只有胜出的治疗组和对照组将继续到研究结束。这种“两阶段胜者设计”基于多重比较、适应性设计和胜者选择的概念。在具有这种设计的研究中,如果在早期阶段进行中期选择,多重性会降低,但适应性会更强。如果在研究接近结束时进行中期选择,情况就会变成传统的多重比较,此时可以应用邓尼特方法。来自“胜者”治疗组的最终检验统计量的无条件分布不再是正态分布,本文给出了其精确分布,但计算需要数值积分。为避免复杂计算,我们提出一种正态近似方法来计算I型错误、检验效能、点估计和置信区间。由于正态分布具有广为人知且吸引人的性质,“胜者设计”可以很容易地进行规划和充分实施,本文通过一个例子进行了说明。我们还详细讨论了如何通过优化中期查看的时间和胜者选择的概率来实际实施所提出的设计。

相似文献

1
Interim treatment selection using the normal approximation approach in clinical trials.临床试验中使用正态近似法的临时治疗选择。
Stat Med. 2008 Feb 20;27(4):597-618. doi: 10.1002/sim.2990.
2
A group-sequential design for clinical trials with treatment selection.一种用于有治疗选择的临床试验的序贯分组设计。
Stat Med. 2008 Dec 20;27(29):6209-27. doi: 10.1002/sim.3436.
3
Exact statistical inference for group sequential trials.序贯试验的精确统计推断。
Biometrics. 1991 Dec;47(4):1399-408.
4
Adaptive Dunnett tests for treatment selection.用于治疗选择的自适应邓尼特检验。
Stat Med. 2008 May 10;27(10):1612-25. doi: 10.1002/sim.3048.
5
Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.序贯等效性检验与重复置信区间及其在正态和二元响应中的应用。
Biometrics. 1993 Mar;49(1):31-43.
6
Evaluation of experiments with adaptive interim analyses.自适应期中分析实验的评估。
Biometrics. 1994 Dec;50(4):1029-41.
7
Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint.在终点为直至某个指定时间点的生存情况的无缝II/III期试验中用于中期适应性调整的贝叶斯预测能力。
Stat Med. 2007 Nov 30;26(27):4925-38. doi: 10.1002/sim.2957.
8
Design considerations in crossover trials with a single interim analysis and serial patient entry.具有单次中期分析和连续患者入组的交叉试验中的设计考量
Biometrics. 1996 Jun;52(2):732-9.
9
A two-stage design for choosing among several experimental treatments and a control in clinical trials.一种用于在临床试验的几种实验性治疗方法和一种对照之间进行选择的两阶段设计。
Biometrics. 1989 Jun;45(2):537-47.
10
A multiple-step selection procedure with sequential protection of preferred treatments.
Biometrics. 1993 Sep;49(3):753-61.

引用本文的文献

1
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
2
Two-stage adaptive enrichment design for testing an active factor.两阶段自适应富集设计用于检验活性因子。
J Biopharm Stat. 2020;30(1):18-30. doi: 10.1080/10543406.2019.1609015. Epub 2019 May 28.
3
Efficient Adaptive Randomization and Stopping Rules in Multi-arm Clinical Trials for Testing a New Treatment.
Seq Anal. 2012;31(4):441-457. doi: 10.1080/07474946.2012.719433.
4
Methods of designing two-stage winner trials with survival outcomes.具有生存结局的两阶段胜者试验的设计方法。
Stat Med. 2014 Apr 30;33(9):1539-63. doi: 10.1002/sim.6070. Epub 2013 Dec 18.